Drug Shortage Report for IFEX
| Report ID | 110477 |
| Drug Identification Number | 02241356 |
| Brand name | IFEX (IFOSFAMIDE) 3 G/VIAL |
| Common or Proper name | Ifex |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | IFOSFAMIDE |
| Strength(s) | 3G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 3g vial |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-04-02 |
| Actual start date | 2020-04-02 |
| Estimated end date | 2020-04-20 |
| Actual end date | 2020-04-20 |
| Shortage status | Resolved |
| Updated date | 2020-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-04-21 | English | Compare |
| v5 | 2020-04-20 | French | Compare |
| v4 | 2020-04-20 | English | Compare |
| v3 | 2020-04-03 | English | Compare |
| v2 | 2020-04-02 | French | Compare |
| v1 | 2020-04-02 | English | Compare |
Showing 1 to 6 of 6